A detailed history of Planned Solutions, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Planned Solutions, Inc. holds 2,149 shares of PFE stock, worth $56,647. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,149
Holding current value
$56,647
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$27.7 - $31.39 $59,527 - $67,457
2,149 New
2,149 $62,000
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $2,407 - $2,764
-93 Reduced 1.13%
8,115 $225,000
Q4 2023

Jan 17, 2024

BUY
$26.13 - $33.94 $42,905 - $55,729
1,642 Added 25.01%
8,208 $236,000
Q3 2023

Feb 06, 2024

SELL
$32.09 - $37.51 $7,605 - $8,889
-237 Reduced 2.89%
7,971 $264,000
Q2 2023

Jul 11, 2023

BUY
$36.12 - $41.79 $9,391 - $10,865
260 Added 4.12%
6,566 $240,000
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $18,495 - $24,143
443 Added 7.56%
6,306 $0
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $8,752 - $10,684
-200 Reduced 3.3%
5,863 $257,000
Q2 2022

Jul 14, 2022

BUY
$46.53 - $55.17 $66,770 - $79,168
1,435 Added 31.01%
6,063 $318,000
Q1 2022

Apr 08, 2022

BUY
$45.75 - $56.69 $19,809 - $24,546
433 Added 10.32%
4,628 $240,000
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $173,337 - $256,943
4,195 New
4,195 $248,000
Q1 2021

Apr 29, 2021

SELL
$33.49 - $37.77 $137,978 - $155,612
-4,120 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $9,204 - $11,704
275 Added 7.15%
4,120 $152,000
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $122,078 - $143,226
3,845 New
3,845 $141,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Planned Solutions, Inc. Portfolio

Follow Planned Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planned Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Planned Solutions, Inc. with notifications on news.